Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Mizrahi

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Treatment Options in Oncology|July 1, 2020
New Treatment Options for Advanced Biliary Tract CancerJonathan D Mizrahi, Rachna T Shroff
Oncotarget|November 9, 2018
Bevacizumab as a chemoprotectant: reducing oxaliplatin induced hepatic sinusoidal injuryJonathan D Mizrahi, Michael J Overman
JCO Oncology Practice|November 26, 2024
Novel Therapies for Pancreatic CancerVictoria Chung, Jonathan D Mizrahi, Shubham Pant
Lancet (London, England)|June 29, 2020
Pancreatic cancerJonathan D Mizrahi, Rishi Surana, Juan W Valle, et al.
World Journal of Gastrointestinal Oncology|January 23, 2020
Multi-institutional retrospective analysis of FOLFIRI in patients with advanced biliary tract cancersJonathan D Mizrahi, Valerie Gunchick, Kabir Mody, et al.
Journal of Gastrointestinal Oncology|March 17, 2020
Dose-modified gemcitabine plus nab-paclitaxel front-line in advanced pancreatic ductal adenocarcinoma with baseline hyperbilirubinemiaJane E Rogers, Jonathan D Mizrahi, Rachna T Shroff, et al.
Journal of Gastrointestinal Oncology|November 18, 2021
Outcomes of patients with metastatic pancreatic cancer who progress on first restaging imagingJane E Rogers, Jonathan D Mizrahi, Graciela M Nogueras Gonzalez, et al.
Cancer Medicine|June 11, 2020
Modified gemcitabine plus nab-paclitaxel regimen in advanced pancreatic ductal adenocarcinomaJane E Rogers, Jonathan D Mizrahi, Lianchun Xiao, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|January 15, 2020
Modified FOLFIRINOX in pancreatic cancer patients Age 75 or olderJonathan D Mizrahi, Jane E Rogers, Kenneth R Hess, et al.
Cancer Medicine|July 12, 2021
Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patientsChirayu Mohindroo, Merve Hasanov, Jane E Rogers, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Treatment Options in Oncology|July 1, 2020
New Treatment Options for Advanced Biliary Tract CancerJonathan D Mizrahi, Rachna T Shroff
Oncotarget|November 9, 2018
Bevacizumab as a chemoprotectant: reducing oxaliplatin induced hepatic sinusoidal injuryJonathan D Mizrahi, Michael J Overman
JCO Oncology Practice|November 26, 2024
Novel Therapies for Pancreatic CancerVictoria Chung, Jonathan D Mizrahi, Shubham Pant
Lancet (London, England)|June 29, 2020
Pancreatic cancerJonathan D Mizrahi, Rishi Surana, Juan W Valle, et al.
World Journal of Gastrointestinal Oncology|January 23, 2020
Multi-institutional retrospective analysis of FOLFIRI in patients with advanced biliary tract cancersJonathan D Mizrahi, Valerie Gunchick, Kabir Mody, et al.
Journal of Gastrointestinal Oncology|March 17, 2020
Dose-modified gemcitabine plus nab-paclitaxel front-line in advanced pancreatic ductal adenocarcinoma with baseline hyperbilirubinemiaJane E Rogers, Jonathan D Mizrahi, Rachna T Shroff, et al.
Journal of Gastrointestinal Oncology|November 18, 2021
Outcomes of patients with metastatic pancreatic cancer who progress on first restaging imagingJane E Rogers, Jonathan D Mizrahi, Graciela M Nogueras Gonzalez, et al.
Cancer Medicine|June 11, 2020
Modified gemcitabine plus nab-paclitaxel regimen in advanced pancreatic ductal adenocarcinomaJane E Rogers, Jonathan D Mizrahi, Lianchun Xiao, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|January 15, 2020
Modified FOLFIRINOX in pancreatic cancer patients Age 75 or olderJonathan D Mizrahi, Jane E Rogers, Kenneth R Hess, et al.
Cancer Medicine|July 12, 2021
Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patientsChirayu Mohindroo, Merve Hasanov, Jane E Rogers, et al.
Pageof 2